Literature DB >> 15919217

Near-infrared radiation protects the red cell membrane against oxidation.

L Chludzińska1, E Ananicz, A Jarosławska, M Komorowska.   

Abstract

The antioxidant effects of near-infrared radiation (NIR) in vitro (700-200 nm) on human erythrocytes was studied as a continuation of our earlier studies. The changes of: ratio of hemolysis, electrokinetic potential, lipids peroxidation, autohemolysis, and fluidity of red cell lipid bilayer were studied for intact, irradiated, ozonated and irradiated, and ozonated erythrocytes. We revealed that, under in vitro condition, the oxidation of red cells by ozone decreased lipids' bilayer fluidity in the vicinity of the 5th carbon and increased fluidity on the 16th carbon level of hydrocarbon chains, induced autohemolysis, oxidized lipids, and changed the electrokinetic potential. However, when erythrocytes were exposed to near-infrared radiation (NIR) and later ozonated, measured parameters were the same as that for control cells kept in darkness or markedly less modified than that ozonated. In conclusion, these observations suggest protective action of NIR radiation on the erythrocyte membrane. The results support the idea that during exposition to NIR, dehydration process induces the photochemical dissociation oxyhemoglobin to deoxyhemoglobin. Deoxygenation leads to phosphorylation of cytoplasmic domain of band 3 at tyrosine 8 that strengthens its association with the spectrin network. An increased association between band 3 and the underlying skeleton elevated the cell membrane mechanical resistance that could protect them before autohemolysis. Also, weakening hydrogen bonds on the surface of erythrocyte membranes moderate the surface charge, lowering the accessibility of charged free radicals from ozone solution into cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919217     DOI: 10.1016/j.bcmd.2005.04.003

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  6 in total

Review 1.  Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.

Authors:  Paolo Cassano; Samuel R Petrie; Michael R Hamblin; Theodore A Henderson; Dan V Iosifescu
Journal:  Neurophotonics       Date:  2016-03-04       Impact factor: 3.593

2.  Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review.

Authors:  Farzad Salehpour; Sevda Gholipour-Khalili; Fereshteh Farajdokht; Farzin Kamari; Tomasz Walski; Michael R Hamblin; Joseph O DiDuro; Paolo Cassano
Journal:  Rev Neurosci       Date:  2020-04-28       Impact factor: 4.353

3.  Low-level light therapy reduces platelet destruction during extracorporeal circulation.

Authors:  Anna Drohomirecka; Alicja Iwaszko; Tomasz Walski; Aleksandra Pliszczak-Król; Grzegorz Wąż; Stanisław Graczyk; Katarzyna Gałecka; Albert Czerski; Jolanta Bujok; Małgorzata Komorowska
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

4.  Near-infrared photobiomodulation of blood reversibly inhibits platelet reactivity and reduces hemolysis.

Authors:  Tomasz Walski; Karolina Grzeszczuk-Kuć; Katarzyna Gałecka; Natalia Trochanowska-Pauk; Raghvendra Bohara; Albert Czerski; Konstanty Szułdrzyński; Wiesław Królikowski; Jerzy Detyna; Małgorzata Komorowska
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

5.  Individual osmotic fragility distribution: a new parameter for determination of the osmotic properties of human red blood cells.

Authors:  Tomasz Walski; Ludmiła Chludzińska; Małgorzata Komorowska; Wojciech Witkiewicz
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

6.  Low-Level Light Therapy Protects Red Blood Cells Against Oxidative Stress and Hemolysis During Extracorporeal Circulation.

Authors:  Tomasz Walski; Anna Drohomirecka; Jolanta Bujok; Albert Czerski; Grzegorz Wąż; Natalia Trochanowska-Pauk; Michał Gorczykowski; Romuald Cichoń; Małgorzata Komorowska
Journal:  Front Physiol       Date:  2018-05-31       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.